Table TDI-11. Characteristics of new clients treated for drug problems: demographics and main drug at treatment in 2002 or most recent year available. Part (i) Demographics and injecting status

Country		Year	No. of clients	Mean age	% Age <25	% Age 35+	% Male	% Injecting main drug

Belgium	⁽¹⁾	1999	4826	24.5	63	13	76	8
Czech Republic	⁽²⁾	2002	4719	21.8	75.8	4.1	67	55.3
Denmark		2002	1062	28.3	44	25	78	10
Germany	⁽⁴⁾	2002	9574	25.9	65	11	81	na
Greece		2002	1787	27.7	47.8	20.8	83.9	47.7
Spain		2002	17228	28.3	37	20	85	5.9
France	⁽⁵⁾	1999	5785	29	31	42	80	na
Ireland	⁽⁶⁾	2000	1981	23.2	68.4	7	77	22.8
Italy	⁽⁷⁾	2002	32892	29.3	32	24.7	87	na
Latvia	⁽⁸⁾	2002	220	23.8	66.4	7.6	73.2	na
Lithuania		2002	471	25.6	69	7	81.3	na
Luxembourg	⁽¹⁰⁾	2002	24	27.3	na	na	na	na
Hungary		2002	4717	na	46	21	62	na
Netherlands	⁽¹²⁾	2002	4847	30.5	35	29	79	3
Austria	⁽¹³⁾	2002	689	26.5	50.7	17.1	74	na
Portugal	⁽¹⁴⁾	2002	5405	31.8	19.2	30.1	83.9	na
Slovenia		2002	528	22.4	75.3	4	73.9	48.7
Slovakia		2002	843	24.6	64.4	9.1	78.7	47.8
Finland		2002	986	24.8	73.4	7	72	38.7
Sweden	⁽¹⁵⁾	2002	545	31	42	32	63	7
United Kingdom	⁽¹⁶⁾	2002	na	na	na	na	na	na

Notes:
		Data were not available for: Estonia, Cyprus, Malta, Poland and Norway.
Belgium	⁽¹⁾	Data refer only to outpatient treatment centres. Last data available refer to 1999.
Czech Republic	⁽²⁾	Data refer to all treatment centres.
Germany	⁽⁴⁾	Data only refer to outpatient treatment centres; information about injecting use is not available.
France	⁽⁵⁾	The last available data on treatment demand are reported, referring to the annual census on clients in treatment carried out in November 1999.
Ireland	⁽⁶⁾	Last data available refer to 2000.
Italy	⁽⁷⁾	Data only refer to outpatient treatment centres; information about injecting opiate use refers only to heroin, for cocaine only to cocaine CIH.
Latvia	⁽⁸⁾	Data refer only to outpatient treatment centres.
Luxembourg	⁽¹⁰⁾	Data on first treatment only partially available.
Netherlands	⁽¹²⁾	Data refer only to outpatient treatment centres.
Austria	⁽¹³⁾	Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are consequently 100%.
Portugal	⁽¹⁴⁾	Coverage is limited and variable, with no control on double counting of clients.
Sweden	⁽¹⁵⁾	Data refer only to out-patient treatment centres.
United Kingdom	⁽¹⁶⁾	Data relate to the period from 1 April 2001 to 31 March 2002 for Scotland and Northern Ireland; for England and Wales six months data ending 30 September 2000 plus six months data ending 31 March 2001.

Associated graphic:
Trends in current injecting drug use amongst heroin users in treatment [Figure9OL].

Sources: 2003 Reitox national reports, Standard table 3, see [Table TDI-10 Part (iii)] for details on sources.

Download